‘Investor Meet Company’ presentation on 20 March

AI SummaryClose X

ImmuPharma PLC will host a live presentation on the 'Investor Meet Company' platform on Friday, March 20, 2026, at 12:00 GMT, featuring its CEO, CSO, and COO. This presentation will discuss the company's announcement from March 17, 2026, which covered an update on P140, the accelerated development of Kapiglucagon for Type 1 Diabetes, and a subscription and WRAP retail offer aiming to raise up to £7.5 million. No new material will be presented, and questions can be submitted in advance or during the meeting.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings